Skip to main content

Table 1 Disease activity score after subcutaneous injection of autologous ultrafiltrates in early rheumatoid patients

From: Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats

Ultrafiltratesa Pts ACR ≥ 20b (10th day) vs (30th day) RR° 95 % CI p value
(%pts10th day) (%pts 30th day)
UF-R rifamycin SV (from 5 × 106 cells/mL) 46 17 (37) 19 (41) 0.90 0.54 1.49 NS
Ul-f/t freeze/taw (from 5 × 106 cells/mL) 58 19 (33) 22 (38) 0.86 0.53 1.42 NS
UF-sf (from acellular sin. fluid) 11 7 (64) 7 (64) 1 0.53 1.88
  1. aOne subcutaneous administration in two consecutive days. For doses, see text
  2. bAmerican College Rheumatology criteria ≥20° relative risks (RR), calculated using Chi square Pearson test